Effectiveness of Dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients

Belgian HIV Research Consortium BREAC

Effectiveness of Dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients

Belgian HIV Research Consortium BREAC

Research output: Contribution to journal › Meeting abstract in journal

Original language	English
Article number	PE2/31
Journal	HIV Medicine
Volume	20
Issue number	S9
Pages (from-to)	68-69
Number of pages	2
ISSN	1464-2662
Publication status	Published - 2019

Cite this

@article{a1e39589bdbb4607bf0541727bb304f8,

title = "Effectiveness of Dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients",

author = "\{Belgian HIV Research Consortium BREAC\} and R. Nasreddine and E. Florence and B. Vandercam and M. Moutschen and J-C Goffard and \{De Munter\}, P. and M. Delforge and \{De Wit\}, S.",

note = "NPP",

year = "2019",

language = "English",

volume = "20",

pages = "68--69",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "John Wiley \& Sons",

number = "S9",

}

TY - JOUR

T1 - Effectiveness of Dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients

AU - Belgian HIV Research Consortium BREAC

AU - Nasreddine, R.

AU - Florence, E.

AU - Vandercam, B.

AU - Moutschen, M.

AU - Goffard, J-C

AU - De Munter, P.

AU - Delforge, M.

AU - De Wit, S.

N1 - NPP

PY - 2019

Y1 - 2019

M3 - Meeting abstract in journal

SN - 1464-2662

VL - 20

SP - 68

EP - 69

JO - HIV Medicine

JF - HIV Medicine

IS - S9

M1 - PE2/31

ER -